Sodium chloride-enriched Diet Enhanced Inflammatory Cytokine Production and Exacerbated Experimental Colitis in Mice

J Crohns Colitis. 2017 Feb;11(2):237-245. doi: 10.1093/ecco-jcc/jjw139. Epub 2016 Jul 29.

Abstract

Background and aim: Environmental factors are supposed to play a decisive role in the pathogenesis of inflammatory bowel diseases [IBDs]. Increased dietary salt intake has been linked with the development of autoimmune diseases, but the impact of a salt-enriched diet on the course of IBD remains unknown. In this study, we examined whether high salt intake alters mucosal cytokine production and exacerbates colitis.

Methods: Normal intestinal lamina propria mononuclear cells [LPMCs] were activated with anti-CD3/CD28 in the presence or absence of increasing concentrations of sodium chloride [NaCl] and/or SB202190, a specific inhibitor of p38/MAP Kinase. For in vivo experiments, a high dose of NaCl was administered to mice 15 days before induction of trinitrobenzene-sulfonic acid [TNBS]-colitis or dextran sulfate sodium [DSS]-colitis. In parallel, mice were given SB202190 before induction of TNBS-colitis. Transcription factors and effector cytokines were evaluated by flow-cytometry and real-time PCR.

Results: IL-17A, IL-23R, TNF-α, and Ror-γT were significantly increased in human LPMCs following NaCl exposure, while there was no significant change in IFN-γ, T-bet or Foxp3. Pharmacologic inhibition of p38/MAPK abrogated the NaCl-inducing effect on LPMC-derived cytokines. Mice receiving the high-salt diet developed a more severe colitis than control mice, and this effect was preventable by SB202190.

Conclusions: Our data indicated that exposure of intestinal mononuclear cells to a high-NaCl diet enhanced effector cytokine production and contributed to the exacerbation of experimental colitis in mice.

Keywords: Crohn’s disease; Salt; TNF-α; inflammatory bowel diseases; p38; ulcerative colitis.

MeSH terms

  • Animals
  • Colitis* / etiology
  • Colitis* / immunology
  • Colitis* / metabolism
  • Colitis* / prevention & control
  • Disease Models, Animal
  • Enzyme Inhibitors / pharmacology
  • Imidazoles / pharmacology*
  • Interleukin-17 / analysis
  • Intestinal Mucosa* / drug effects
  • Intestinal Mucosa* / immunology
  • Intestinal Mucosa* / pathology
  • Mice
  • Protective Agents / pharmacology
  • Pyridines / pharmacology*
  • Receptors, Interleukin / analysis
  • Sodium Chloride, Dietary* / administration & dosage
  • Sodium Chloride, Dietary* / adverse effects
  • Sodium Chloride, Dietary* / metabolism
  • Statistics as Topic
  • Treatment Outcome
  • Tumor Necrosis Factor-alpha / analysis
  • p38 Mitogen-Activated Protein Kinases / antagonists & inhibitors

Substances

  • Enzyme Inhibitors
  • Imidazoles
  • Interleukin-17
  • Protective Agents
  • Pyridines
  • Receptors, Interleukin
  • Sodium Chloride, Dietary
  • Tumor Necrosis Factor-alpha
  • interleukin-23 receptor, mouse
  • p38 Mitogen-Activated Protein Kinases
  • 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole